A biotechnology company focused on the discovery, development and commercialization of cancer therapy products.


Updates from The Motley Fool

Latest updates on Poniard Pharmaceuticals, Inc. from Fool.com.


Stock Performance

View Interactive PARD Charts
Sponsored by

Key Data Points

Primary metrics and data points about Poniard Pharmaceuticals, Inc..
Current Price: $0.05
Prev Close: $0.05
Open: $0.00
Bid: $0.00
Ask: $0.00
Day's Range: $0.00 - $0.00
52wk Range: $0.04 - $0.21
Volume: 0
Avg Vol 1,190
Market Cap: $75MM
P/E (ttm): -0.00
EPS (ttm): $0.00
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Poniard Pharmaceuticals, Inc..
CAPS Rating 0 out of 5
 
46 Outperform
9 Underperform
CAPS All Stars
 
10 Outperform
2 Underperform

How do you think Poniard Pharmaceuticals, Inc. will perform against the market?



You pick for Poniard Pharmaceuticals, Inc. is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Eric Domb, CEO

0% Approve

Based on 0 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Poniard Pharmaceuticals, Inc..

A biotechnology company focused on the discovery, development and commercialization of cancer therapy products.

  • Exchange: NASDAQOTH
  • Sector: Healthcare
  • Industry: Biotech